BACKGROUND: Falls occur in 28% of hemodialysis patients and increase the risk of physical impairment, morbidity, and mortality. Therefore, it is likely that KT candidates with recurrent falls are less likely to access KT and more likely to experience adverse post-KT outcomes. METHODS: We used a two-center cohort study of KT candidates (n=3666) and recipients (n=770) (1/2009-1/2018). Among candidates, we estimated time to listing, waitlist mortality, and transplant rate by recurrent falls (≥2 falls) prior to evaluation using adjusted regression. Among KT recipients, we estimated risk of mortality, graft loss, and length of stay (LOS) by recurrent falls prior to KT using adjusted regression. RESULTS: Candidates with recurrent falls (6.5%) had a lower chance of listing (aHR=0.68,95%CI:0.56-0.83) but not transplant rate; waitlist mortality was 31-fold (95%CI:11.33-85.93) higher in the first year and gradually decreased over time. Recipients with recurrent falls (5.1%) were at increased risk of mortality (aHR=51.43,95%CI:16.00-165.43) and graft loss (aHR=33.57,95%CI:11.24-100.21) in the first year, which declined over time, and a longer LOS (aRR=1.13,95%CI:1.02-1.25). In summary, 6.5% of KT candidates and 5.1% of recipients experienced recurrent falls which were associated with adverse pre- and post-KT outcomes. CONCLUSIONS: While recurrent falls were relatively rare in KT candidates and recipients, they were associated with adverse outcomes. Transplant centers should consider employing fall prevention strategies for high-risk candidates as part of comprehensive prehabilitation.
BACKGROUND: Falls occur in 28% of hemodialysis patients and increase the risk of physical impairment, morbidity, and mortality. Therefore, it is likely that KT candidates with recurrent falls are less likely to access KT and more likely to experience adverse post-KT outcomes. METHODS: We used a two-center cohort study of KT candidates (n=3666) and recipients (n=770) (1/2009-1/2018). Among candidates, we estimated time to listing, waitlist mortality, and transplant rate by recurrent falls (≥2 falls) prior to evaluation using adjusted regression. Among KT recipients, we estimated risk of mortality, graft loss, and length of stay (LOS) by recurrent falls prior to KT using adjusted regression. RESULTS: Candidates with recurrent falls (6.5%) had a lower chance of listing (aHR=0.68,95%CI:0.56-0.83) but not transplant rate; waitlist mortality was 31-fold (95%CI:11.33-85.93) higher in the first year and gradually decreased over time. Recipients with recurrent falls (5.1%) were at increased risk of mortality (aHR=51.43,95%CI:16.00-165.43) and graft loss (aHR=33.57,95%CI:11.24-100.21) in the first year, which declined over time, and a longer LOS (aRR=1.13,95%CI:1.02-1.25). In summary, 6.5% of KT candidates and 5.1% of recipients experienced recurrent falls which were associated with adverse pre- and post-KT outcomes. CONCLUSIONS: While recurrent falls were relatively rare in KT candidates and recipients, they were associated with adverse outcomes. Transplant centers should consider employing fall prevention strategies for high-risk candidates as part of comprehensive prehabilitation.
Authors: Mara A McAdams-DeMarco; Hao Ying; Sarah Van Pilsum Rasmussen; Jennifer Schrack; Christine E Haugen; Nadia M Chu; Marlís González Fernández; Niraj Desai; Jeremy D Walston; Dorry L Segev Journal: Clin Transplant Date: 2018-12-21 Impact factor: 2.863
Authors: Mara A McAdams-DeMarco; Hao Ying; Alvin G Thomas; Fatima Warsame; Ashton A Shaffer; Christine E Haugen; Jacqueline M Garonzik-Wang; Niraj M Desai; Ravi Varadhan; Jeremy Walston; Silas P Norman; Dorry L Segev Journal: Transplantation Date: 2018-10 Impact factor: 4.939
Authors: Xingxing S Cheng; Jonathan N Myers; Glenn M Chertow; Ralph Rabkin; Khin N Chan; Yu Chen; Jane C Tan Journal: Clin Transplant Date: 2017-07-10 Impact factor: 2.863
Authors: Mara A McAdams-DeMarco; Elizabeth A King; Xun Luo; Christine Haugen; Sandra DiBrito; Ashton Shaffer; Lauren M Kucirka; Niraj M Desai; Nabil N Dagher; Bonnie E Lonze; Robert A Montgomery; Jeremy Walston; Dorry L Segev Journal: Ann Surg Date: 2017-12 Impact factor: 12.969
Authors: Mara A McAdams-DeMarco; Sunitha Suresh; Andrew Law; Megan L Salter; Luis F Gimenez; Bernard G Jaar; Jeremy D Walston; Dorry L Segev Journal: BMC Nephrol Date: 2013-10-16 Impact factor: 2.388